Some anecdotal reports and preliminary long-term studies suggest that continuous treatment could help preserve positive behavioral changes, but definitive evidence is lacking
Common Questions About Tirzepatide Is tirzepatide better than semaglutide
Relevant model outputs include life expectancy, quality-adjusted life expectancy (expressed in quality-adjusted life years [QALYs]), direct costs, time to onset of diabetes-related complications, cost-effectiveness scatterplots and acceptability curves, and incremental cost-effectiveness ratios (ICERs)
Progressive overload is the solution
This unique mechanism potentially offers enhanced benefits for weight management and glycemic control
Patients with simple steatosis who have not yet progressed to MASH lack approved pharmacological options, and current clinical management primarily depends on lifestyle modification, which is often limited by poor adherence and inconsistent therapeutic outcomes